DE3925759A1 - Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe - Google Patents
Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxeInfo
- Publication number
- DE3925759A1 DE3925759A1 DE19893925759 DE3925759A DE3925759A1 DE 3925759 A1 DE3925759 A1 DE 3925759A1 DE 19893925759 DE19893925759 DE 19893925759 DE 3925759 A DE3925759 A DE 3925759A DE 3925759 A1 DE3925759 A1 DE 3925759A1
- Authority
- DE
- Germany
- Prior art keywords
- ace inhibitors
- captopril
- atheroskleroseprophylaxe
- patients
- atherosclerosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893925759 DE3925759A1 (de) | 1989-08-03 | 1989-08-03 | Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe |
EP19900113765 EP0411395A3 (en) | 1989-08-03 | 1990-07-18 | Use of ace inhibitors for atherosclerosis-prophylaxis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893925759 DE3925759A1 (de) | 1989-08-03 | 1989-08-03 | Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3925759A1 true DE3925759A1 (de) | 1991-02-07 |
Family
ID=6386477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19893925759 Withdrawn DE3925759A1 (de) | 1989-08-03 | 1989-08-03 | Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP0411395A3 (fr) |
DE (1) | DE3925759A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212165A (en) * | 1989-10-23 | 1993-05-18 | E. R. Squibb & Sons, Inc. | Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
US5061694A (en) * | 1989-10-23 | 1991-10-29 | E. R. Squibb & Sons, Inc. | Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
AU714618B2 (en) * | 1996-07-15 | 2000-01-06 | Sankyo Company Limited | Medicinal composition |
WO2005020984A2 (fr) * | 2003-08-29 | 2005-03-10 | Aaipharma Inc. | Methode de reduction du stress oxydatif |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3536687A1 (de) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA896851B (en) * | 1988-09-14 | 1990-06-27 | Hoffmann La Roche | Use of ace-inhibitors |
-
1989
- 1989-08-03 DE DE19893925759 patent/DE3925759A1/de not_active Withdrawn
-
1990
- 1990-07-18 EP EP19900113765 patent/EP0411395A3/de not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3536687A1 (de) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
Also Published As
Publication number | Publication date |
---|---|
EP0411395A2 (fr) | 1991-02-06 |
EP0411395A3 (en) | 1991-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Karunanayake et al. | Oral hypoglycaemic activity of some medicinal plants of Sri Lanka | |
DE69822665T2 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
EP0279382B1 (fr) | Moyen contre les verrues | |
DE3328262C2 (fr) | ||
WO1994020139A1 (fr) | Utilisation d'anticorps anti-tnf comme medicament therapeutique de l'insuffisance cardiaque (faiblesse du muscle cardiaque) | |
EP0586909A2 (fr) | Utilisation du C1-inhibiteur pour l'obtention d'un médicament destiné au traitement prophylactique et thérapeutique du capillary leak syndroms et du choc circulatoire | |
CH661869A5 (de) | Arzneimittel zur behandlung der ulkuskrankheit. | |
DE69420776T2 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
DE69730214T2 (de) | Zusammensetzung und verfahren zur behandlung von herpes simplex | |
DE2206570C3 (de) | Verwendung von (+)-Catechin | |
EP0331014A2 (fr) | L'utilisation des inhibiteurs de l'enzyme de conversion pour la prophylaxie du diabète | |
DE3925759A1 (de) | Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe | |
EP0668768B1 (fr) | Composition permettant de lutter contre les dermatomycoses et leurs agents causals, ainsi que contre la sudation et les odeurs corporelles | |
DE2037942C2 (de) | Arzneimittel enthaltend ein "aktives" Chondroitinsulfat als Wirkstoff zur Verhinderung des Auftretens atherosklerotischer Läsionen und zur Verhinderung des Auftretens von Herzanfällen | |
DE19633446B4 (de) | Arzneimittel mit lipidsenkender Wirkung | |
EP0211093B1 (fr) | Médicament pour le traitement de l'herpès | |
EP2548564B1 (fr) | Produit pharmaceutique, alimentation d'un patient et procédé de réduction du poids | |
Vuopala et al. | Dimethyl Sulfoxide (DMSO) Ointment in the Treatment of Rheumatoid Arthritis: A Double Blind Study | |
Edirisinghe et al. | Effect of Sapa Vireka Choorna on Vibandha (Mala Adassiya/Chronic Constipation)–Series of case studies | |
DE3780702T2 (de) | Verwendung von etodolac zur senkung des blutgehalts an harnsaeure. | |
DE10247339A1 (de) | Psoriasisbehandlung | |
DE1667891A1 (de) | Neue therapeutische Zusammensetzungen mit analgetischer Wirksamkeit | |
DE4236409C1 (de) | Verwendung eines Präparates zur Behandlung von Diabetes mellitus | |
Osato | Beiträge zum Studium der Lymphe III. Mitteilung. Die saccharifizierenden Fermente und der Zuckergehalt | |
DE4244754C2 (de) | Bekämpfung der Erreger von Dermatomykosen in Bekleidungsstücken |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8130 | Withdrawal |